Induced differentiation inhibits sphere formation in neuroblastoma

Brian T. Craig, Eric J. Rellinger, Alexandra L. Alvarez, Haley L. Dusek, Jingbo Qiao, Dai H. Chung

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Neuroblastoma arises from the neural crest, the precursor cells of the sympathoadrenal axis, and differentiation status is a key prognostic factor used for clinical risk group stratification and treatment strategies. Neuroblastoma tumor-initiating cells have been successfully isolated from patient tumor samples and bone marrow using sphere culture, which is well established to promote growth of neural crest stem cells. However, accurate quantification of sphere-forming frequency of commonly used neuroblastoma cell lines has not been reported. Here, we show that MYCN-amplified neuroblastoma cell lines form spheres more frequently than non-MYCN-amplified cell lines. We also show that sphere formation is directly sensitive to cellular differentiation status. 13-cis-retinoic acid is a clinically used differentiating agent that induces a neuronal phenotype in neuroblastoma cells. Induced differentiation nearly completely blocked sphere formation. Furthermore, sphere formation was specifically FGF-responsive and did not respond to increasing doses of EGF. Taken together, these data suggest that sphere formation is an accurate method of quantifying the stemness phenotype in neuroblastoma.

Original languageEnglish (US)
Pages (from-to)255-259
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume477
Issue number2
DOIs
StatePublished - Aug 19 2016
Externally publishedYes

Fingerprint

Neuroblastoma
Neural Crest
Cell Line
Cells
Tumors
Phenotype
Isotretinoin
Neural Stem Cells
Neoplastic Stem Cells
Epidermal Growth Factor
Stem cells
Bone Marrow
Bone
Growth
Neoplasms

Keywords

  • Cancer stem cell
  • Limiting dilution analysis
  • Neuroblastoma
  • Retinoic acid
  • Sphere assay

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Induced differentiation inhibits sphere formation in neuroblastoma. / Craig, Brian T.; Rellinger, Eric J.; Alvarez, Alexandra L.; Dusek, Haley L.; Qiao, Jingbo; Chung, Dai H.

In: Biochemical and Biophysical Research Communications, Vol. 477, No. 2, 19.08.2016, p. 255-259.

Research output: Contribution to journalArticle

Craig, Brian T. ; Rellinger, Eric J. ; Alvarez, Alexandra L. ; Dusek, Haley L. ; Qiao, Jingbo ; Chung, Dai H. / Induced differentiation inhibits sphere formation in neuroblastoma. In: Biochemical and Biophysical Research Communications. 2016 ; Vol. 477, No. 2. pp. 255-259.
@article{17875e53be94419eac4fea35e4d5a61a,
title = "Induced differentiation inhibits sphere formation in neuroblastoma",
abstract = "Neuroblastoma arises from the neural crest, the precursor cells of the sympathoadrenal axis, and differentiation status is a key prognostic factor used for clinical risk group stratification and treatment strategies. Neuroblastoma tumor-initiating cells have been successfully isolated from patient tumor samples and bone marrow using sphere culture, which is well established to promote growth of neural crest stem cells. However, accurate quantification of sphere-forming frequency of commonly used neuroblastoma cell lines has not been reported. Here, we show that MYCN-amplified neuroblastoma cell lines form spheres more frequently than non-MYCN-amplified cell lines. We also show that sphere formation is directly sensitive to cellular differentiation status. 13-cis-retinoic acid is a clinically used differentiating agent that induces a neuronal phenotype in neuroblastoma cells. Induced differentiation nearly completely blocked sphere formation. Furthermore, sphere formation was specifically FGF-responsive and did not respond to increasing doses of EGF. Taken together, these data suggest that sphere formation is an accurate method of quantifying the stemness phenotype in neuroblastoma.",
keywords = "Cancer stem cell, Limiting dilution analysis, Neuroblastoma, Retinoic acid, Sphere assay",
author = "Craig, {Brian T.} and Rellinger, {Eric J.} and Alvarez, {Alexandra L.} and Dusek, {Haley L.} and Jingbo Qiao and Chung, {Dai H.}",
year = "2016",
month = "8",
day = "19",
doi = "10.1016/j.bbrc.2016.06.053",
language = "English (US)",
volume = "477",
pages = "255--259",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Induced differentiation inhibits sphere formation in neuroblastoma

AU - Craig, Brian T.

AU - Rellinger, Eric J.

AU - Alvarez, Alexandra L.

AU - Dusek, Haley L.

AU - Qiao, Jingbo

AU - Chung, Dai H.

PY - 2016/8/19

Y1 - 2016/8/19

N2 - Neuroblastoma arises from the neural crest, the precursor cells of the sympathoadrenal axis, and differentiation status is a key prognostic factor used for clinical risk group stratification and treatment strategies. Neuroblastoma tumor-initiating cells have been successfully isolated from patient tumor samples and bone marrow using sphere culture, which is well established to promote growth of neural crest stem cells. However, accurate quantification of sphere-forming frequency of commonly used neuroblastoma cell lines has not been reported. Here, we show that MYCN-amplified neuroblastoma cell lines form spheres more frequently than non-MYCN-amplified cell lines. We also show that sphere formation is directly sensitive to cellular differentiation status. 13-cis-retinoic acid is a clinically used differentiating agent that induces a neuronal phenotype in neuroblastoma cells. Induced differentiation nearly completely blocked sphere formation. Furthermore, sphere formation was specifically FGF-responsive and did not respond to increasing doses of EGF. Taken together, these data suggest that sphere formation is an accurate method of quantifying the stemness phenotype in neuroblastoma.

AB - Neuroblastoma arises from the neural crest, the precursor cells of the sympathoadrenal axis, and differentiation status is a key prognostic factor used for clinical risk group stratification and treatment strategies. Neuroblastoma tumor-initiating cells have been successfully isolated from patient tumor samples and bone marrow using sphere culture, which is well established to promote growth of neural crest stem cells. However, accurate quantification of sphere-forming frequency of commonly used neuroblastoma cell lines has not been reported. Here, we show that MYCN-amplified neuroblastoma cell lines form spheres more frequently than non-MYCN-amplified cell lines. We also show that sphere formation is directly sensitive to cellular differentiation status. 13-cis-retinoic acid is a clinically used differentiating agent that induces a neuronal phenotype in neuroblastoma cells. Induced differentiation nearly completely blocked sphere formation. Furthermore, sphere formation was specifically FGF-responsive and did not respond to increasing doses of EGF. Taken together, these data suggest that sphere formation is an accurate method of quantifying the stemness phenotype in neuroblastoma.

KW - Cancer stem cell

KW - Limiting dilution analysis

KW - Neuroblastoma

KW - Retinoic acid

KW - Sphere assay

UR - http://www.scopus.com/inward/record.url?scp=84976623361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976623361&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2016.06.053

DO - 10.1016/j.bbrc.2016.06.053

M3 - Article

C2 - 27297102

AN - SCOPUS:84976623361

VL - 477

SP - 255

EP - 259

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -